论文部分内容阅读
目的:探讨未破裂型输卵管妊娠的腹腔镜下保守性手术的临床治疗效果。方法:选取建瓯市立医院2012年1月-2014年12月期间收治的55例有生育要求的未破裂型输卵管妊娠患者作为观察组,均在腹腔镜下行输卵管切开、输卵管胚胎吸除术,对这55例患者采取腹腔镜保守手术治疗方法,另选同期采用甲氨蝶呤药物治疗的未破裂型输卵管妊娠患者55例,观察组对比两组患者的治疗效果,包括住院时间、住院所用费用以及最终患者的输卵管复通率。结果:经过观察对比,观察组中治疗成功患者47例,手术成功率为85.5%,对照组中治疗成功44例,手术成功率为80.0%,两组手术成功率比较,差异无统计学意义(P>0.05);观察组患者的住院时间明显少于对照组,住院所用费用明显高于对照组,且观察组患者的输卵管复通率也明显高于对照组,差异具有统计学意义(P<0.05)。结论:腹腔镜下保守性手术治疗未破裂型输卵管妊娠临床效果良好,比保守性药物治疗效果要好,可以大大降低患者住院时间,提高患者输卵管复通率,加快血β人绒毛膜促性腺激素(β-HCG)降至正常时间,降低患者并发症发生率,安全可靠,术后患者恢复较快。
Objective: To investigate the clinical effect of laparoscopic conservative surgery for unruptured tubal pregnancy. Methods: Fifty-five patients with unruptured tubal pregnancy requiring childbearing who were admitted to Jian’ou Municipal Hospital from January 2012 to December 2014 were selected as the observation group. All patients underwent laparoscopic tubal incision, tubal embryo aspiration, 55 cases of these patients to take conservative treatment of laparoscopic surgery, the other with the same period methotrexate treatment of unruptured tubal pregnancy in 55 patients, the observation group compared two groups of patients, including the length of stay, hospitalization costs As well as the final patient’s tubal regurgitation rate. Results: After observation and comparison, 47 patients were successfully treated in the observation group. The successful rate of operation was 85.5%. In the control group, 44 patients were successfully treated. The successful rate of operation was 80.0%. There was no significant difference in the success rate between the two groups P> 0.05). The hospitalization time in the observation group was significantly less than that in the control group, the cost for hospitalization was significantly higher than that in the control group, and the tubal recanalization rate in the observation group was also significantly higher than that in the control group (P < 0.05). Conclusion: The conservative treatment of laparoscopic unruptured tubal pregnancy has a good clinical effect, better than the conservative drug treatment, which can greatly reduce the hospitalization time, improve the patient’s tubal recanalization rate and speed up the blood β human chorionic gonadotropin ( β-HCG) to normal time, reduce the incidence of complications in patients with safe and reliable postoperative patients recover faster.